• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达氟沙星在绵羊体内的药代动力学及组织分布

Pharmacokinetics and tissue disposition of danofloxacin in sheep.

作者信息

McKellar Q A, Gibson I F, McCormack R Z

机构信息

Department of Veterinary Pharmacology, University of Glasgow Veterinary School, UK.

出版信息

Biopharm Drug Dispos. 1998 Mar;19(2):123-9. doi: 10.1002/(sici)1099-081x(199803)19:2<123::aid-bdd89>3.0.co;2-g.

DOI:10.1002/(sici)1099-081x(199803)19:2<123::aid-bdd89>3.0.co;2-g
PMID:9533113
Abstract

The plasma pharmacokinetics of danofloxacin administered at 1.25 mg kg-1 body weight by the intravenous and intramuscular routes were determined in sheep. Tissue distribution was also determined following administration by the intramuscular route at 1.25 mg kg-1 body weight. Danofloxacin had a large volume of distribution at steady state (Vdss) of 2.76 +/- 0.16 h (mean +/- S.E.M.) L kg-1, an elimination half-life (t1/2 beta) of 3.35 +/- 0.23 h, and a body clearance (C1) of 0.63 +/- 0.04 L kg-1 h-1. Following intramuscular administration it achieved a maximum concentration (Cmax) of 0.32 +/- 0.02 microgram mL-1 at 1.23 +/- 0.34 h (tmax) and had a mean residence time (MRT) of 5.45 +/- 0.19 h. Danofloxacin had an absolute bioavailability (F) of 95.71 +/- 4.41% and a mean absorption time (MAT) of 0.81 +/- 0.20 h following intramuscular administration. Mean plasma concentrations of > 0.06 microgram mL-1 were maintained for more than 8 h following intravenous and intramuscular administration. Following intramuscular administration highest concentrations were measured in plasma (0.43 +/- 0.04 microgram mL-1), lung (1.51 +/- 0.18 micrograms g-1), and interdigital skin (0.64 +/- 0.18 microgram g-1) at 1 h, duodenal contents (0.81 +/- 0.40 microgram mL-1), lymph nodes (4.61 +/- 0.35 micrograms g-1), and brain (0.06 +/- 0.00 microgram mL-1) at 2 h, jejunal (10.50 +/- 4.31 micrograms mL-1) and ileal (5.25 +/- 1.67 micrograms mL-1) contents at 4 h, and colonic contents (8.94 +/- 0.65 micrograms mL-1) at 8 h.

摘要

通过静脉注射和肌肉注射途径,以1.25毫克/千克体重的剂量给绵羊注射达氟沙星,测定其血浆药代动力学。还测定了以1.25毫克/千克体重肌肉注射给药后的组织分布情况。达氟沙星稳态时的分布容积(Vdss)为2.76±0.16升/千克(平均值±标准误),消除半衰期(t1/2β)为3.35±0.23小时,机体清除率(C1)为0.63±0.04升/千克/小时。肌肉注射后,在1.23±0.34小时(达峰时间)达到最大浓度(Cmax)为0.32±0.02微克/毫升,平均驻留时间(MRT)为5.45±0.19小时。肌肉注射后,达氟沙星的绝对生物利用度(F)为95.71±4.41%,平均吸收时间(MAT)为0.81±0.20小时。静脉注射和肌肉注射后,血浆平均浓度>0.06微克/毫升可维持8小时以上。肌肉注射后,1小时时血浆(0.43±0.04微克/毫升)、肺(1.51±0.18微克/克)和趾间皮肤(0.64±0.18微克/克)中测得的浓度最高,2小时时十二指肠内容物(0.81±0.40微克/毫升)、淋巴结(4.61±0.35微克/克)和脑(0.06±0.00微克/毫升)中浓度最高,4小时时空肠(10.55±4.31微克/毫升)和回肠(5.25±1.67微克/毫升)内容物中浓度最高,8小时时结肠内容物(8.94±0.65微克/毫升)中浓度最高。

相似文献

1
Pharmacokinetics and tissue disposition of danofloxacin in sheep.达氟沙星在绵羊体内的药代动力学及组织分布
Biopharm Drug Dispos. 1998 Mar;19(2):123-9. doi: 10.1002/(sici)1099-081x(199803)19:2<123::aid-bdd89>3.0.co;2-g.
2
Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens.肉鸡中达氟沙星和恩诺沙星的血浆药代动力学及组织浓度的比较研究。
J Vet Pharmacol Ther. 1999 Aug;22(4):239-46. doi: 10.1046/j.1365-2885.1999.00217.x.
3
Clinical pharmacokinetics of parenterally administered danofloxacin in cattle.静脉注射达氟沙星在牛体内的临床药代动力学
J Vet Pharmacol Ther. 1991 Dec;14(4):400-10. doi: 10.1111/j.1365-2885.1991.tb00854.x.
4
Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia.
Am J Vet Res. 1993 Jun;54(6):937-43.
5
Pharmacokinetics of danofloxacin 18% in lactating sheep and goats.18% 达氟沙星在泌乳绵羊和山羊体内的药代动力学
J Vet Pharmacol Ther. 2007 Dec;30(6):572-7. doi: 10.1111/j.1365-2885.2007.00898.x.
6
Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes.达氟沙星在母羊体内的药代动力学及从血液到乳汁的渗透情况。
Vet Res. 1997 Nov-Dec;28(6):571-9.
7
Effect of water deprivation on the disposition kinetics of enrofloxacin in camels.
J Vet Pharmacol Ther. 1995 Oct;18(5):333-9. doi: 10.1111/j.1365-2885.1995.tb00600.x.
8
Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations.恩诺沙星在健康猪口服和肌肉注射后在肠道组织及内容物中的分布。
J Vet Pharmacol Ther. 2002 Oct;25(5):335-42. doi: 10.1046/j.1365-2885.2002.00430.x.
9
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.恩诺沙星及其代谢产物环丙沙星在绵羊静脉注射和肌肉注射后的药代动力学
Am J Vet Res. 1996 Jul;57(7):1040-3.
10
Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration.
J Vet Pharmacol Ther. 1997 Apr;20(2):124-8. doi: 10.1046/j.1365-2885.1997.00814.x.

引用本文的文献

1
Influence of Dexamethasone on the Plasma and Milk Disposition Kinetics of Danofloxacin in Lactating Sheep.地塞米松对哺乳期绵羊血浆及乳汁中达氟沙星处置动力学的影响
Vet Sci. 2025 Mar 1;12(3):210. doi: 10.3390/vetsci12030210.
2
Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections.单剂量或与美洛昔康联合给药后,达氟沙星在健康羔羊和患有呼吸道感染的羔羊体内的药代动力学行为及药代动力学/药效学整合
Antibiotics (Basel). 2021 Sep 30;10(10):1190. doi: 10.3390/antibiotics10101190.
3
Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.
氟甲喹在猪饮用水治疗给药后在肠道内容物和结肠组织中的分布
Animals (Basel). 2021 May 23;11(6):1514. doi: 10.3390/ani11061514.
4
Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.支原体在体外模型中对丹氟沙星 PK/PD 参数的关系与耐药性的产生和机制。
PLoS One. 2018 Aug 29;13(8):e0202070. doi: 10.1371/journal.pone.0202070. eCollection 2018.
5
The PK-PD Relationship and Resistance Development of Danofloxacin against in An Infection Model.达氟沙星在感染模型中对[具体对象]的药代动力学-药效学关系及耐药性发展
Front Microbiol. 2017 May 30;8:926. doi: 10.3389/fmicb.2017.00926. eCollection 2017.
6
Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin.猪 ABcb1 基因:分子克隆、组织分布、功能分析及其对恩诺沙星药代动力学的影响。
Sci Rep. 2016 Aug 30;6:32244. doi: 10.1038/srep32244.
7
Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis).在水牛犊牛(Bubalus bubalis)静脉注射后,丹氟沙星的药代动力学、尿排泄和血浆蛋白结合。
Vet Res Commun. 2009 Oct;33(7):659-67. doi: 10.1007/s11259-009-9215-6. Epub 2009 Mar 19.
8
Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.甲磺酸达氟沙星是ATP依赖性外排转运蛋白的底物。
Br J Pharmacol. 2007 Feb;150(4):463-9. doi: 10.1038/sj.bjp.0706974. Epub 2007 Jan 8.
9
Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids.达氟沙星在绵羊生物体液中的药代动力学(PK)、药效动力学(PD)及PK-PD整合
Antimicrob Agents Chemother. 2003 Feb;47(2):626-35. doi: 10.1128/AAC.47.2.626-635.2003.
10
Some pharmacokinetic parameters of pefloxacin in lactating goats.培氟沙星在泌乳山羊体内的一些药代动力学参数。
Vet Res Commun. 2002 Oct;26(7):553-61. doi: 10.1023/a:1020243615928.